Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
The currently available antiviral treatments (Peg-Interferon-α and Nucleos(t)ide Analogues, NA) for chronic hepatitis B (CHB) achieve a functional cure (serum HBsAg and HDV-DNA clearance) of HBV infection in a limited number of patients. Nevertheless, the continuous pharmacological suppression of vi...
Main Authors: | Piero Colombatto, Barbara Coco, Ferruccio Bonino, Maurizia R. Brunetto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/4/701 |
Similar Items
-
Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine
by: Gian Paolo Caviglia, et al.
Published: (2017-12-01) -
HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
by: Ferruccio Bonino, et al.
Published: (2022-07-01) -
Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
by: Elisabetta Degasperi, et al.
Published: (2022-10-01) -
Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
by: Bei Jiang, et al.
Published: (2022-12-01) -
Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
by: Yi-Tse Su, et al.
Published: (2022-08-01)